The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Regarding safety, mNexspike was found to have a similar profile to Moderna’s original COVID-19 vaccine; injection site pain, fatigue, headache, and myalgia were the most commonly solicited ...

As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...

COVID vaccine stocks are in focus as RFK Jr. revamps the National Vaccine Injury Compensation Program to support people ...

Get Instant Summarized Text (Gist) The FDA has approved Moderna's mNexspike, a lower-dose mRNA COVID-19 vaccine designed to elicit a focused immune response with about one-fifth the dose of Spikevax.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.. The new vaccine is indicated for active immunization to prevent COVID-19 caused ...